175 related articles for article (PubMed ID: 35275240)
1. Diabetes, GDF-15 and incident heart failure: the atherosclerosis risk in communities study.
Echouffo-Tcheugui JB; Daya N; Ndumele CE; Matsushita K; Hoogeveen RC; Ballantyne CM; Coresh J; Shah AM; Selvin E
Diabetologia; 2022 Jun; 65(6):955-963. PubMed ID: 35275240
[TBL] [Abstract][Full Text] [Related]
2. Growth Differentiation Factor (GDF)-15 and Cardiometabolic Outcomes among Older Adults: The Atherosclerosis Risk in Communities Study.
Echouffo-Tcheugui JB; Daya N; Matsushita K; Wang D; Ndumele CE; Al Rifai M; Hoogeveen RC; Ballantyne CM; Selvin E
Clin Chem; 2021 Mar; 67(4):653-661. PubMed ID: 33582779
[TBL] [Abstract][Full Text] [Related]
3. Galectin-3, Metabolic Risk, and Incident Heart Failure: The ARIC Study.
Echouffo-Tcheugui JB; Zhang S; Florido R; Pankow JS; Michos ED; Goldberg RB; Nambi V; Gerstenblith G; Post WS; Blumenthal RS; Ballantyne CM; Coresh J; Selvin E; Ndumele CE
J Am Heart Assoc; 2024 Mar; 13(6):e031607. PubMed ID: 38471823
[TBL] [Abstract][Full Text] [Related]
4. Change in Cardiac Biomarkers and Risk of Incident Heart Failure and Atrial Fibrillation in CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.
Bansal N; Zelnick LR; Soliman EZ; Anderson A; Christenson R; DeFilippi C; Deo R; Feldman HI; He J; Ky B; Kusek J; Lash J; Seliger S; Shafi T; Wolf M; Go AS; Shlipak MG;
Am J Kidney Dis; 2021 Jun; 77(6):907-919. PubMed ID: 33309861
[TBL] [Abstract][Full Text] [Related]
5. Growth differentiation factor 15 is positively associated with incidence of diabetes mellitus: the Malmö Diet and Cancer-Cardiovascular Cohort.
Bao X; Borné Y; Muhammad IF; Nilsson J; Lind L; Melander O; Niu K; Orho-Melander M; Engström G
Diabetologia; 2019 Jan; 62(1):78-86. PubMed ID: 30350239
[TBL] [Abstract][Full Text] [Related]
6. Duration of Diabetes and Incident Heart Failure: The ARIC (Atherosclerosis Risk In Communities) Study.
Echouffo-Tcheugui JB; Zhang S; Florido R; Hamo C; Pankow JS; Michos ED; Goldberg RB; Nambi V; Gerstenblith G; Post WS; Blumenthal RS; Ballantyne CM; Coresh J; Selvin E; Ndumele CE
JACC Heart Fail; 2021 Aug; 9(8):594-603. PubMed ID: 34325890
[TBL] [Abstract][Full Text] [Related]
7. Circulating Growth Differentiation Factors 11 and 8, Their Antagonists Follistatin and Follistatin-Like-3, and Risk of Heart Failure in Elders.
Kizer JR; Patel S; Ganz P; Newman AB; Bhasin S; Lee SJ; Cawthon PM; LeBrasseur NK; Shah SJ; Psaty BM; Tracy RP; Cummings SR
J Gerontol A Biol Sci Med Sci; 2024 Jan; 79(1):. PubMed ID: 37624693
[TBL] [Abstract][Full Text] [Related]
8. Cardiac Biomarkers and Risk of Incident Heart Failure in Chronic Kidney Disease: The CRIC (Chronic Renal Insufficiency Cohort) Study.
Bansal N; Zelnick L; Go A; Anderson A; Christenson R; Deo R; Defilippi C; Lash J; He J; Ky B; Seliger S; Soliman E; Shlipak M; ;
J Am Heart Assoc; 2019 Nov; 8(21):e012336. PubMed ID: 31645163
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of long-term changes of growth differentiation factor-15 over a 27-year-period for heart failure and death due to coronary heart disease.
Fluschnik N; Ojeda F; Zeller T; Jørgensen T; Kuulasmaa K; Becher PM; Sinning C; Blankenberg S; Westermann D
PLoS One; 2018; 13(5):e0197497. PubMed ID: 29771963
[TBL] [Abstract][Full Text] [Related]
10. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction.
Khan SQ; Ng K; Dhillon O; Kelly D; Quinn P; Squire IB; Davies JE; Ng LL
Eur Heart J; 2009 May; 30(9):1057-65. PubMed ID: 19168526
[TBL] [Abstract][Full Text] [Related]
11. Growth Differentiation Factor 15 and the Subsequent Risk of Atrial Fibrillation: The Atherosclerosis Risk in Communities Study.
Chen M; Ding N; Mok Y; Mathews L; Hoogeveen RC; Ballantyne CM; Chen LY; Coresh J; Matsushita K
Clin Chem; 2022 Jul; 68(8):1084-1093. PubMed ID: 35762561
[TBL] [Abstract][Full Text] [Related]
12. Association Between Circulating GDF-15 and Cardio-Renal Outcomes and Effect of Canagliflozin: Results From the CANVAS Trial.
Sen T; Li J; Neuen BL; Arnott C; Neal B; Perkovic V; Mahaffey KW; Shaw W; Canovatchel W; Hansen MK; Heerspink HJL
J Am Heart Assoc; 2021 Dec; 10(23):e021661. PubMed ID: 34854308
[TBL] [Abstract][Full Text] [Related]
13. Growth differentiation factor-15 is not modified by sacubitril/valsartan and is an independent marker of risk in patients with heart failure and reduced ejection fraction: the PARADIGM-HF trial.
Bouabdallaoui N; Claggett B; Zile MR; McMurray JJV; O'Meara E; Packer M; Prescott MF; Swedberg K; Solomon SD; Rouleau JL;
Eur J Heart Fail; 2018 Dec; 20(12):1701-1709. PubMed ID: 30204280
[TBL] [Abstract][Full Text] [Related]
14. Neighborhood Disadvantage and Risk of Heart Failure: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study.
Malla G; Long DL; Cherrington A; Goyal P; Guo B; Safford MM; Khodneva Y; Cummings DM; McAlexander TP; DeSilva S; Judd SE; Hidalgo B; Levitan EB; Carson AP
Circ Cardiovasc Qual Outcomes; 2024 Mar; 17(3):e009867. PubMed ID: 38328917
[TBL] [Abstract][Full Text] [Related]
15. Towards a multi-marker prognostic strategy in acute heart failure: a role for GDF-15.
Bettencourt P; Ferreira-Coimbra J; Rodrigues P; Marques P; Moreira H; Pinto MJ; Guimarães JT; Lourenço P
ESC Heart Fail; 2018 Dec; 5(6):1017-1022. PubMed ID: 30144302
[TBL] [Abstract][Full Text] [Related]
16. Serum magnesium, phosphorus, and calcium are associated with risk of incident heart failure: the Atherosclerosis Risk in Communities (ARIC) Study.
Lutsey PL; Alonso A; Michos ED; Loehr LR; Astor BC; Coresh J; Folsom AR
Am J Clin Nutr; 2014 Sep; 100(3):756-64. PubMed ID: 25030784
[TBL] [Abstract][Full Text] [Related]
17. Utility of Growth Differentiation Factor-15, A Marker of Oxidative Stress and Inflammation, in Chronic Heart Failure: Insights From the HF-ACTION Study.
Sharma A; Stevens SR; Lucas J; Fiuzat M; Adams KF; Whellan DJ; Donahue MP; Kitzman DW; Piña IL; Zannad F; Kraus WE; O'Connor CM; Felker GM
JACC Heart Fail; 2017 Oct; 5(10):724-734. PubMed ID: 28958347
[TBL] [Abstract][Full Text] [Related]
18. Growth differentiation factor 15 as mortality predictor in heart failure patients with non-reduced ejection fraction.
Mendez Fernandez AB; Ferrero-Gregori A; Garcia-Osuna A; Mirabet-Perez S; Pirla-Buxo MJ; Cinca-Cuscullola J; Ordonez-Llanos J; Roig Minguell E
ESC Heart Fail; 2020 Oct; 7(5):2223-2229. PubMed ID: 32589369
[TBL] [Abstract][Full Text] [Related]
19. Soluble neprilysin, NT-proBNP, and growth differentiation factor-15 as biomarkers for heart failure in dialysis patients (SONGBIRD).
Claus R; Berliner D; Bavendiek U; Vodovar N; Lichtinghagen R; David S; Patecki M; Launay JM; Bauersachs J; Haller H; Hiss M; Balzer MS
Clin Res Cardiol; 2020 Aug; 109(8):1035-1047. PubMed ID: 32002632
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of Growth differentiation factors 15 in Acute heart failure patients with preserved ejection fraction.
Yin D; Yan X; Bai X; Tian A; Gao Y; Li J
ESC Heart Fail; 2023 Apr; 10(2):1025-1034. PubMed ID: 36519216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
